Why the consumer protection body asked for Sensodyne ad to be scrapped

The Central Consumer Protection Authority has directed GlaxoSmithKline to discontinue advertisements for Sensodyne products.

About Central Consumer Protection Authority (CCPA):

The authority is being constituted under Section 10(1) of The Consumer Protection Act, 2019.
Aim: To protect the rights of the consumer by cracking down on unfair trade practices, and false and misleading advertisements that are detrimental to the interests of the public and consumers.
It will be headquartered in the National Capital Region of Delhi but the central government may set up regional offices in other parts of the country.
The objective of the Central Consumer Protection Authority (CCPA) is to promote, protect and enforce the rights of consumers as a class.
It will be empowered to conduct investigations into violation of consumer rights and institute complaints / prosecution,
order recall of unsafe goods and services, order discontinuation of unfair trade practices and misleading advertisements,
impose penalties on manufacturers/endorsers/publishers of misleading advertisements.
Composition: It will have a Chief Commissioner as head, and only two other commissioners as members, one of whom will deal with matters relating to goods while the other will look into cases relating to services.
The CCPA will have an Investigation Wing that will be headed by a Director General.
District Collectors too, will have the power to investigate complaints of violations of consumer rights, unfair trade practices, and false or misleading advertisements.

Why has GSK been asked to discontinue certain advertisements for Sensodyne?

The CCPA found that certain advertisements for Sensodyne products broadcast on television, Youtube, Facebook and Twitter showed UK-based dentists recommending Sensodyne products.
Dentists practising in India are not permitted to endorse any drug or product of the industry publically under the Revised Dentists (Code of Ethics) Regulations 2014.